J Obes Metab Syndr 32(1):2545 Tian S, Zhou S, Wu W, lin Y, Wang T, Sun H, et al (2025) GLP-1 Receptor agonists alleviate diabetic kidney injury via -klotho-mediated ferroptosis inhibition
Still expensive, but P.B
While the drug labels for many GLP-1 medications mentioned common side effects like nausea, vomiting, and diarrhea, it is alleged that they failed to adequately warn of the risk of developing severe, permanent conditions like gastroparesis
In 2024, about 1 in every 8 adults in the U.S
Medicare-eligible patients may qualify for FDA-approved GLP-1 medications for as little as a $50 copay through the Medicare GLP-1 Bridge Program, while compounded medications are available for $140 per 4-week supply
Are they under-fueling relative to their activity